| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 06/23/2004 | CN1506362A Resin process of extracting proanthocyanidin from graup seed |
| 06/23/2004 | CN1506361A Low temperature proanthocyanidin extracting process from grape seed |
| 06/23/2004 | CN1506360A Method of extracting effective components in kudzu vine root |
| 06/23/2004 | CN1506359A Coumarin amide derivative and its prepn, medicinal composition and use |
| 06/23/2004 | CN1154642C Pyranone compounds useful to treat retroviral infections |
| 06/23/2004 | CN1154488C Immuno inhibitort |
| 06/17/2004 | WO2004050609A1 Substituted ureas and carbamates |
| 06/17/2004 | WO2004050082A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 06/17/2004 | WO2004050011A2 High enantiomeric purity dexanabinol for pharmaceutical copositions |
| 06/17/2004 | US20040116718 Therapy for breast cancer; plant extracts |
| 06/17/2004 | US20040116717 Isolation from plants; extraction of dried wood powder; hexane and chloroform as solvents; solvent extraction; concentration; adsorption on silica gel |
| 06/17/2004 | US20040116716 Antioxidant from natural source |
| 06/17/2004 | US20040116445 Substituted thioacetamides |
| 06/17/2004 | US20040116443 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 06/17/2004 | US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 06/17/2004 | US20040116355 Caspase inhibitors and the use thereof |
| 06/17/2004 | CA2507815A1 High enantiomeric purity dexanabinol for pharmaceutical compositions |
| 06/17/2004 | CA2507484A1 Substituted ureas and carbamates |
| 06/16/2004 | EP1427717A1 Bioprecursors for percutaneous application |
| 06/16/2004 | EP1248778B1 Substituted photochromic 2h-naphtho 1,2-b] pyran compounds |
| 06/16/2004 | EP1237885B1 Method for preparing dl-alpha-tocopherol with a high yield and high purity |
| 06/16/2004 | EP1089963B1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 06/16/2004 | EP1071658B1 Btk inhibitors and methods for their identification and use |
| 06/16/2004 | CN1505621A Process for the preparation of isoflavones |
| 06/16/2004 | CN1505620A Process for purification of warfarin acid, warfarin alkali metal salts and corresponding clathrates |
| 06/16/2004 | CN1505619A Preparation of warfarin sodium from warfarin sodium 2-propanol clathrate by nondestructive solvent expulsion |
| 06/16/2004 | CN1505618A Dimeric isoflavones |
| 06/16/2004 | CN1504467A Extraction technology for seabuckthorn leaf general flavone |
| 06/16/2004 | CN1153768C Process for extracting medicinal component from pueraria root |
| 06/15/2004 | US6750359 From various oils; recovering fatty acids, tocopherols, and sterols; condensation zones |
| 06/15/2004 | US6750357 Rhodamine-based fluorophores useful as labeling reagents |
| 06/15/2004 | US6750255 Calcium receptor-active compounds |
| 06/15/2004 | US6750249 Gradually release esculetin or its derivative in a controlled manner over a long period of time |
| 06/15/2004 | US6750248 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 06/15/2004 | US6750244 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 06/10/2004 | WO2004048335A2 Mandelic acid derivatives |
| 06/10/2004 | WO2004047847A1 Efficient method for producing compositions enriched in total phenols |
| 06/10/2004 | WO2004047674A2 Oxyge-containing heterocyclic fused naphthopyrans |
| 06/10/2004 | WO2004030440A3 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 06/10/2004 | WO2003102140A3 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 06/10/2004 | WO2003101950A3 Methods for enhancing motor performance and/or endurance |
| 06/10/2004 | US20040110827 Has the 3S,4S configuration and is >99.90% over the 3R,4R enantiomer; nervous system disorders; chronic neurodegenerative diseases, CNS poisoning, cognition activators; antiinflammatory agents; autoimmune diseases; side effect reduction |
| 06/10/2004 | US20040110790 A flavonoids, anticarcinogenic agents for treating cancer, such as catechin, epigallocatichin-3-gallate |
| 06/10/2004 | US20040110750 Ortho-diihydroxy- coumarin or 1,2--dihydroquinoline derivatives as catechol-O-methyltransferase enzyme inhibitors for Parkinson*s disease treatment |
| 06/10/2004 | US20040110745 Serotonin (5-HT) receptor antagonists; psychiatric, eating , sexual, panic, psychological, gastrointestinal, cardiovascular, and sleep disorders; headaches, dementia |
| 06/10/2004 | US20040110257 Production of farnesol and geranylgeraniol |
| 06/10/2004 | US20040109882 Use of flavones, flavanones and flavonoids for protecting ascorbic acid and/or ascorbyl compounds from oxidation |
| 06/10/2004 | CA2506651A1 Efficient method for producing compositions enriched in total phenols |
| 06/10/2004 | CA2505542A1 Mandelic acid derivatives |
| 06/09/2004 | EP1426378A1 2-benzoylchromone derivatives |
| 06/09/2004 | EP1426368A1 Method for extracting and purifying natural tocopherols and sterols by esterification with trimethyl propane |
| 06/09/2004 | EP1426361A1 Novel composition containing a bi-cyclic compound and a glyceride |
| 06/09/2004 | EP1426048A2 Treating hypertriglyceridemia with RXR agonists in combination with a PPARgamma agonist |
| 06/09/2004 | EP1425030A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 06/09/2004 | DE10256174A1 2-Benzoylchromonderivate 2-Benzoylchromonderivate |
| 06/09/2004 | CN1503789A Process for producing nitrile compound |
| 06/09/2004 | CN1152679C Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent |
| 06/08/2004 | US6747059 Composition for, and methods of, anti-platelet therapy |
| 06/03/2004 | WO2004046162A2 Non-steroidal fxr agonists |
| 06/03/2004 | WO2004046127A1 MANUFACTURE OF α-TOCOPHEROL |
| 06/03/2004 | WO2004046126A1 Manufacture of tocopheryl acetate |
| 06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 06/03/2004 | WO2004046068A2 Non-steroidal farnesoid x receptor modulators and methods for the use thereof |
| 06/03/2004 | WO2004045603A1 Medicinal composition for treating sudden deafness |
| 06/03/2004 | WO2004045557A2 Novel lapachone compounds and methods of use thereof |
| 06/03/2004 | WO2004045511A2 Non-steroidal farnesoid x receptor modulators |
| 06/03/2004 | WO2004033448A3 Isolation, purification and synthesis of procyanidin b2 and uses thereof |
| 06/03/2004 | WO2004019888A3 Process to prepare psorospermin |
| 06/03/2004 | WO2003079965A3 Derivatives of isoflavones |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | US20040106808 Processes for preparing calanolide a and intermediates thereof |
| 06/03/2004 | US20040106611 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106595 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof |
| 06/03/2004 | US20040105864 Food supplement |
| 06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
| 06/02/2004 | EP1424013A1 A method of extracting and isolating minor components from vegetable oil |
| 06/02/2004 | EP1423105A2 Combinations of dmxaa and other anti-cancer agents |
| 06/02/2004 | EP1423099A1 A new extended release oral dosage form |
| 06/02/2004 | CN1500794A Rose hip general extract and producing technology thereof |
| 06/02/2004 | CN1500773A Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 06/02/2004 | CN1500769A Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
| 06/01/2004 | US6743615 Converting trimethylhydroquinone diacetate (tmhq-da) into the corresponding monoacetate (tmhq-1-ma) with a lipase |
| 06/01/2004 | CA2146646C Benzopyranones, method of preparing them and their use |
| 05/27/2004 | WO2004043946A1 Cannabinoid crystalline derivatives and process of cannabinoid purification |
| 05/27/2004 | WO2004043945A1 Method for purifying and separating soy isoflavones |
| 05/27/2004 | WO2002081462A8 Aminoflavone compounds, compositions, and methods of use thereof |
| 05/27/2004 | US20040102639 Preparation of isocoumarin derivatives and intermediates for the synthesis thereof |
| 05/27/2004 | US20040102516 Crop protection agents |
| 05/27/2004 | US20040102515 Deprotecting a xanthenenone compound containing O-protecting group and a oxirane ring substitued with methyl containing a leaving group in presence of palladium/barium sulfate and 1,4-dicyclohexadiene, or Raney Nickel |
| 05/27/2004 | US20040102491 Antimicrobial agents |
| 05/27/2004 | US20040102488 Antiinflamamtory agents; autoimmune diseases; antiarthritic agents; anticancer agents; Alzheimer's disease |
| 05/27/2004 | US20040102479 Novel benzopyran or thiobenzopyran derivatives |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102386 Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto |
| 05/27/2004 | US20040102356 Bicyclic lactones, perfumery uses thereof, processes for preparing same and intermediates therefor |
| 05/27/2004 | US20040101839 Novel functional peptide nucleic acid monomer and process for producing the same |
| 05/27/2004 | US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer |
| 05/27/2004 | DE10252532A1 Pure homoeriodictyol sodium salt recovery, for use as flavoring or antiinflammatory agent, by extracting Eriodictyon plant material with water-immiscible solvent, dewaxing and precipitating with base |
| 05/27/2004 | CA2770448A1 Cannabinoid esters |